Early research (Phase 1)UnknownNCT04941339What this trial is testingMRG002 in the Treatment of Patients With HER2-positive Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor Shanghai Miracogen Inc. 74
Testing effectiveness (Phase 2)Study completedNCT00005861What this trial is testingLiposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial CancerWho this might be right forEndometrial Cancer Gynecologic Oncology Group
Testing effectiveness (Phase 2)UnknownNCT03813641What this trial is testingRALOX or CAPOX + Bevacizumab in the First-line Treatment of Advanced CRC(ROCB Study)Who this might be right forColorectal Cancer Shenzhen People's Hospital 100
Not applicableLooking for participantsNCT07407231What this trial is testingCombined Chemotherapy And Ablative Radiotherapy (SBRT) As First-Line Treatment In Locally Advanced Inoperable Pancreatic Cancer (SBRT-PANC)Who this might be right forLocally Advanced Pancreatic Cancer Institute of Oncology Ljubljana 18
Not applicableNot Yet RecruitingNCT07798102What this trial is testingEffect of Simulation-Based First Aid and Basic Health Training on Parents of Children With Special NeedWho this might be right forFirst Aid TrainingHealth Education Ankara Yildirim Beyazıt University 66
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06213519What this trial is testingHIPEC Combined With SOX and Sintilimab in the Treatment of Advanced Gastric Cancer With Peritoneal MetastasisWho this might be right forPeritoneal MetastasesGastric Cancer Sichuan University 69
Testing effectiveness (Phase 2)UnknownNCT03400592What this trial is testingStudy of Nimotuzumab and Irinotecan as Second Line With Recurrent or Metastatic Gastric AdenocarcinomaWho this might be right forStomach Neoplasms Peking University 55
Large-scale testing (Phase 3)Looking for participantsNCT03703271What this trial is testingStudy of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic NeoplasiaWho this might be right forGestational Trophoblastic Neoplasia Women's Hospital School Of Medicine Zhejiang University 70
Testing effectiveness (Phase 2)WithdrawnNCT00408967What this trial is testingDetermine if Either of 2 Doses of Study Drug Given With a Low-dose of Cyclophosphamide After a Complete or Partial Response to a Platinum-based Second-line Therapy in Women With Recurrent Ovarian Carcinoma Results in a Longer Time to Progression When Compared to the First Time to Progression.Who this might be right forOvarian Cancer EMD Serono
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07457177What this trial is testingPhaes Ⅱ Study of Golidocitinib-Pegaspargase-PD-1 Antibody First-Line for Advanced ENKTLWho this might be right forNK T-Cell Lymphoma LIANG WANG 40
Large-scale testing (Phase 3)Study completedNCT04039607What this trial is testingNivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Bristol-Myers Squibb 732
Testing effectiveness (Phase 2)Looking for participantsNCT06437353What this trial is testingSurufatinib Combined With Carboplatin/Paclitaxel and Surufatinib Combined With Olaparib as First-line and Maintenance Therapy for Newly Diagnosed High-risk Ovarian CancerWho this might be right forOvarian Cancer Anhui Provincial Cancer Hospital 74
Testing effectiveness (Phase 2)UnknownNCT05431764What this trial is testingWhole-target Consolidation Therapy Under Systemic Therapy for Oligometastatic Nasopharyngeal CarcinomaWho this might be right forNasopharyngeal Carcinoma Sun Yat-sen University 38
Early research (Phase 1)Active Not RecruitingNCT06532344What this trial is testingAn Open-label, Uncontrolled Study of ONO-7913 and ONO-4538 in Combination With Modified FOLFIRINOX Therapy, the Standard of Care, as First-line Treatment in Patients With Metastatic Pancreatic CancerWho this might be right forMetastatic Pancreatic Cancer Ono Pharmaceutical Co., Ltd. 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT03816163What this trial is testingZolbetuximab (IMAB362) in Adults With Pancreatic CancerWho this might be right forPancreatic CancerMetastatic Pancreatic CancerMetastatic Pancreatic Adenocarcinoma Astellas Pharma Global Development, Inc. 393
Large-scale testing (Phase 3)Study completedNCT00333775What this trial is testingBevacizumab (Avastin) in Women With HER2 Negative Metastatic Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche 736
Large-scale testing (Phase 3)UnknownNCT04022967What this trial is testingANRS 12372 MODERATO StudyWho this might be right forHIV-1-infection ANRS, Emerging Infectious Diseases 480
Not applicableStudy completedNCT04934800What this trial is testingProspective Effectiveness and Safety Study of Cladribine in Participants Who Change First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS)Who this might be right forMultiple Sclerosis Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 256
Testing effectiveness (Phase 2)Study completedNCT00633464What this trial is testingRandomized Phase II Study of Ixabepilone Alone and Ixabepilone Plus Cetuximab as First-Line Treatment for Female Subjects With Triple Negative Locally Advanced Non-resectable and/or Metastatic Breast CancerWho this might be right forTriple Negative Locally Advanced Non-resectable Breast CancerMetastatic Breast Cancer R-Pharm 79
Testing effectiveness (Phase 2)Study completedNCT03727971What this trial is testingTreatment With the Anti-IgE Monoclonal Antibody Omalizumab in Women With Asthma Undergoing Fertility Treatment. - A Proof of Concept Study.Who this might be right forAsthmaInfertility, Female Rigshospitalet, Denmark 66